Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Nick Reynolds

Newcastle AuthorsTitleYearFull text
Professor Nick Reynolds
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: Statistical analysis plan for stage two of the APRICOT trial2020
Dr Shyamal Wahie
Professor Nick Reynolds
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic Study2020
Professor Nick Reynolds
HLA-C*06:02 genotype is a predictive biomarker of biologic treatment response in psoriasis2019
Dr Nina Wilson
Professor Nick Reynolds
Association of Serum Ustekinumab Levels with Clinical Response in Psoriasis2019
Professor Nick Reynolds
Clinical and genetic differences between pustular psoriasis subtypes2019
Dr Nina Wilson
Professor Nick Reynolds
Defining the therapeutic range for adalimumab and predicting response in psoriasis: amulticenter prospective observational cohort study2019
Dr Robert Ellis
Dr Diana Tang
Dr Batoul Nasr
Alison Greenwood
Dr Ashleigh McConnell
et al.
Epidermal autophagy and beclin 1 regulator 1 and loricrin: a paradigm shift in the prognostication and stratification of the American Joint Committee on Cancer stage I melanomas2019
Professor Nick Reynolds
Identifying demographic, social and clinical predictors of biologic therapy effectiveness in psoriasis: a multicentre longitudinal cohort study2019
Dr Louis Gardner
Dr Henry Grantham
Professor Nick Reynolds
IL-17 May Be a Key Cytokine Linking Psoriasis and Hyperglycemia2019
Professor Nick Reynolds
Infliximab is associated with an increased risk of serious infection in patients with psoriasis in the U.K. and Republic of Ireland: results from the British Association of Dermatologists Biologic Interventions Register (BADBIR)2019
1234567891011121314151617181920